A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings

NCT04940039 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
93
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Janssen-Cilag International NV